Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-17

Clinical Trial Update: SENSIMED Triggerfish in Closed Eyes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update indicates completion of the SENSIMED Triggerfish study for glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SENSIMED Triggerfish

Snippet

Sponsor: Sensimed AG | Conditions: Glaucoma | Phase 4 | Status: COMPLETED